Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127399102 | 12739910 | 2 | F | 20160905 | 20160921 | 20160913 | 20160929 | EXP | JP-ASTRAZENECA-2016SE95954 | ASTRAZENECA | 0.00 | M | Y | 0.00000 | 20160929 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127399102 | 12739910 | 1 | PS | CASODEX | BICALUTAMIDE | 1 | Oral | 1680 | MG | Y | 20498 | 80 | MG | TABLET | QD | ||||
| 127399102 | 12739910 | 2 | SS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 10.8 | MG | Y | 0 | 10.8 | MG | IMPLANT |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127399102 | 12739910 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127399102 | 12739910 | Fall | |
| 127399102 | 12739910 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127399102 | 12739910 | 1 | 20160816 | 20160905 | 0 | |
| 127399102 | 12739910 | 2 | 20160830 | 20160905 | 0 |